LDN and Cancer Information

Akbar Khan, MD
Dr Akbar Khan
Medicor Cancer Centres

Low Dose Naltrexone (LDN) and Cancer Information

The recent paper by Dalgleish and others suggested that stopping LDN for a couple of days around a single chemo dose may enhance the effects of LDN. We have tried that in practice and so far have not seen any dramatic difference compares to continuous dosing. I think it will take a fair-sized human study to demonstrate if the benefit of this protocol exists outside the lab. I think there is no need to stop LDN for a week before and after chemo. We use LDN continuously along with chemo for our patients on capecitabine.